NM_153700.2:c.4561C>T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_153700.2(STRC):​c.4561C>T​(p.Arg1521Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00353 in 1,611,700 control chromosomes in the GnomAD database, including 115 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1521Q) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0050 ( 18 hom., cov: 29)
Exomes 𝑓: 0.0034 ( 97 hom. )

Consequence

STRC
NM_153700.2 missense

Scores

5
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.518

Publications

5 publications found
Variant links:
Genes affected
STRC (HGNC:16035): (stereocilin) This gene encodes a protein that is associated with the hair bundle of the sensory hair cells in the inner ear. The hair bundle is composed of stiff microvilli called stereocilia and is involved with mechanoreception of sound waves. This gene is part of a tandem duplication on chromosome 15; the second copy is a pseudogene. Mutations in this gene cause autosomal recessive non-syndromic deafness. [provided by RefSeq, Jul 2008]
CKMT1B (HGNC:1995): (creatine kinase, mitochondrial 1B) Mitochondrial creatine (MtCK) kinase is responsible for the transfer of high energy phosphate from mitochondria to the cytosolic carrier, creatine. It belongs to the creatine kinase isoenzyme family. It exists as two isoenzymes, sarcomeric MtCK and ubiquitous MtCK, encoded by separate genes. Mitochondrial creatine kinase occurs in two different oligomeric forms: dimers and octamers, in contrast to the exclusively dimeric cytosolic creatine kinase isoenzymes. Many malignant cancers with poor prognosis have shown overexpression of ubiquitous mitochondrial creatine kinase; this may be related to high energy turnover and failure to eliminate cancer cells via apoptosis. Ubiquitous mitochondrial creatine kinase has 80% homology with the coding exons of sarcomeric mitochondrial creatine kinase. Two genes located near each other on chromosome 15 have been identified which encode identical mitochondrial creatine kinase proteins. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0073873997).
BP6
Variant 15-43601536-G-A is Benign according to our data. Variant chr15-43601536-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 165306.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 18 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
STRCNM_153700.2 linkc.4561C>T p.Arg1521Trp missense_variant Exon 24 of 29 ENST00000450892.7 NP_714544.1 Q7RTU9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
STRCENST00000450892.7 linkc.4561C>T p.Arg1521Trp missense_variant Exon 24 of 29 5 NM_153700.2 ENSP00000401513.2 Q7RTU9

Frequencies

GnomAD3 genomes
AF:
0.00504
AC:
766
AN:
151914
Hom.:
18
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00268
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000722
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.0393
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00318
Gnomad OTH
AF:
0.00384
GnomAD2 exomes
AF:
0.00491
AC:
1234
AN:
251096
AF XY:
0.00488
show subpopulations
Gnomad AFR exome
AF:
0.00253
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000218
Gnomad FIN exome
AF:
0.0365
Gnomad NFE exome
AF:
0.00304
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00337
AC:
4919
AN:
1459668
Hom.:
97
Cov.:
32
AF XY:
0.00340
AC XY:
2467
AN XY:
726172
show subpopulations
African (AFR)
AF:
0.00320
AC:
107
AN:
33462
American (AMR)
AF:
0.000738
AC:
33
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26104
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39674
South Asian (SAS)
AF:
0.000394
AC:
34
AN:
86202
European-Finnish (FIN)
AF:
0.0358
AC:
1909
AN:
53372
Middle Eastern (MID)
AF:
0.00330
AC:
19
AN:
5762
European-Non Finnish (NFE)
AF:
0.00237
AC:
2630
AN:
1110052
Other (OTH)
AF:
0.00302
AC:
182
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
272
544
817
1089
1361
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00503
AC:
765
AN:
152032
Hom.:
18
Cov.:
29
AF XY:
0.00654
AC XY:
486
AN XY:
74316
show subpopulations
African (AFR)
AF:
0.00268
AC:
111
AN:
41466
American (AMR)
AF:
0.000721
AC:
11
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4814
European-Finnish (FIN)
AF:
0.0393
AC:
416
AN:
10588
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00316
AC:
215
AN:
67946
Other (OTH)
AF:
0.00380
AC:
8
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
33
65
98
130
163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00253
Hom.:
2
Bravo
AF:
0.00213
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.00250
AC:
11
ESP6500EA
AF:
0.00256
AC:
22
ExAC
AF:
0.00451
AC:
547
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00241
EpiControl
AF:
0.00244

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
May 03, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Arg1521Trp in exon 24 of STRC: This variant is not expected to have clinical s ignificance because it has been identified in 3.9% (254/6588) of Finnish chromos omes including 8 homozygotes by the Exome Aggregation Consortium (ExAC, http://e xac.broadinstitute.org; dbSNP rs138763871), and the arginine (Arg) residue at po sition 1521 is not conserved through species. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.23
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T;.
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.32
FATHMM_MKL
Benign
0.064
N
LIST_S2
Benign
0.78
T;T
MetaRNN
Benign
0.0074
T;T
MetaSVM
Benign
-0.63
T
PhyloP100
0.52
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-2.3
N;N
REVEL
Uncertain
0.36
Sift
Uncertain
0.0050
D;D
Sift4G
Uncertain
0.0040
D;D
Polyphen
0.99
D;D
Vest4
0.52
MVP
0.84
ClinPred
0.020
T
GERP RS
0.40
Varity_R
0.095
gMVP
0.36
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138763871; hg19: chr15-43893734; COSMIC: COSV55853401; COSMIC: COSV55853401; API